Last edition
News about "Acquires Avivia to Bolster Complex Formulation Cap"
Ofichem Group Acquires Avivia to Bolster Complex Formulation Capabilities
Avivia is known for its focus on preformulation, formulation, and analytical method development for challenging pharmaceutical products. The acquisition aligns with Ofichem’s broader strategy to become a fully integrated CDMO, offering end-to-end services from active pharmaceutical ingredient (API) development to GMP manufacturing.
Acquires Avivia To Bolster Complex Formulation Cap | 11/07/2025 | By Darshana | 401
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy